{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:56Z","timestamp":1707524816042},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,22]]},"DOI":"10.7759\/cureus.31798","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T23:16:08Z","timestamp":1669158968000},"source":"Crossref","is-referenced-by-count":0,"title":["Heparin-Induced Thrombocytopenia at the Emergency Department Due to Intermittent Heparin Flush in a Patient Undergoing Stem Cell Transplant"],"prefix":"10.7759","author":[{"given":"Kyaw Z","family":"Thein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A","family":"Elsaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie Q","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristhiam  M","family":"Rojas Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elsayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7566","article-title":"Heparin induced thrombocytopenia","volume":"350","author":"Linkins LA","year":"2015","unstructured":"Linkins LA. Heparin induced thrombocytopenia. BMJ. 2015, 350:g7566. 10.1136\/bmj.g7566","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618165","article-title":"Combination of 4Ts score and PF4\/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study","volume":"126","author":"Linkins LA","year":"2015","unstructured":"Linkins LA, Bates SM, Lee AY, Heddle NM, Wang G, Warkentin TE. Combination of 4Ts score and PF4\/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study. Blood. 2015, 126:597-603. 10.1182\/blood-2014-12-618165","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1523-z","article-title":"Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer","volume":"44","author":"Wong M","year":"2017","unstructured":"Wong M, Oo TH, Qiao W, Garg N, Rojas-Hernandez CM. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer. J Thromb Thrombolysis. 2017, 44:261-6. 10.1007\/s11239-017-1523-z","journal-title":"J Thromb Thrombolysis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin TE","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995, 332:1330-5. 10.1056\/NEJM199505183322003","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin TE","year":"2001","unstructured":"Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001, 135:502-6. 10.7326\/0003-4819-135-7-200110020-00009","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin TE","year":"1996","unstructured":"Warkentin TE, JG Kelton. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996, 101:502-7. 10.1016\/s0002-9343(96)00258-6","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin TE","year":"2001","unstructured":"Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001, 344:1286-92. 10.1056\/NEJM200104263441704","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lab.2005.08.003","article-title":"Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?","volume":"146","author":"Warkentin TE","year":"2005","unstructured":"Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?. J Lab Clin Med. 2005, 146:341-6. 10.1016\/j.lab.2005.08.003","journal-title":"J Lab Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03687.x","article-title":"Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin","volume":"118","author":"Lindhoff-Last E","year":"2002","unstructured":"Lindhoff-Last E, Nakov R, Misselwitz F, Breddin HK, Bauersachs R. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol. 2002, 118:1137-42. 10.1046\/j.1365-2141.2002.03687.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00527.x","article-title":"Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases","volume":"246","author":"Kadidal VV","year":"1999","unstructured":"Kadidal VV, Mayo DJ, Horne MK. Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases. J Intern Med. 1999, 246:325-9. 10.1046\/j.1365-2796.1999.00527.x","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-1-143_1","article-title":"Heparin flushes and thrombocytopenia","volume":"105","author":"Heeger PS","year":"1986","unstructured":"Heeger PS, Backstrom JT. Heparin flushes and thrombocytopenia. Ann Intern Med. 1986, 105:143. 10.7326\/0003-4819-105-1-143_1","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199812000-00037","article-title":"Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia","volume":"89","author":"Ling E","year":"1998","unstructured":"Ling E, Warkentin TE. Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia. Anesthesiology. 1998, 89:1567-9. 10.1097\/00000542-199812000-00037","journal-title":"Anesthesiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1067\/mva.1988.avs0070667","article-title":"Heparin-coated catheters and heparin-induced thrombocytopenia","volume":"7","author":"Laster J","year":"1988","unstructured":"Laster J, Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg. 1988, 7:667-72. 10.1067\/mva.1988.avs0070667","journal-title":"J Vasc Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis BE","year":"2001","unstructured":"Lewis BE, Wallis DE, Berkowitz SD, et al.. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001, 103:1838-43. 10.1161\/01.cir.103.14.1838","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"164","author":"Hirsh J","year":"2004","unstructured":"Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med. 2004, 164:361-9. 10.1001\/archinte.164.4.361","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin TE","year":"2008","unstructured":"Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008, 133:340S-80S. 10.1378\/chest.08-0677","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang M","year":"2015","unstructured":"Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2015, 125:924-9. 10.1182\/blood-2014-09-599498","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G738","article-title":"Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia","volume":"40","author":"Efird LE","year":"2006","unstructured":"Efird LE, Kockler DR. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Ann Pharmacother. 2006, 40:1383-7. 10.1345\/aph.1G738","journal-title":"Ann Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel R","year":"2015","unstructured":"Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood. 2015, 125:1470-6. 10.1182\/blood-2014-10-605493","journal-title":"Blood"},{"key":"ref20","article-title":"Heparin-induced thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement","volume":"24","author":"Ishibashi H","year":"2005","unstructured":"Ishibashi H, Takashi O, Hoska M, et al.. Heparin-induced thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement. Int Angiol. 2005, 24:387-90.","journal-title":"Int Angiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115234-heparin-induced-thrombocytopenia-at-the-emergency-department-due-to-intermittent-heparin-flush-in-a-patient-undergoing-stem-cell-transplant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:24Z","timestamp":1707507804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115234-heparin-induced-thrombocytopenia-at-the-emergency-department-due-to-intermittent-heparin-flush-in-a-patient-undergoing-stem-cell-transplant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.31798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}